Speakers

Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 9th MASH Drug Development Summit.

MASH Drug Development Summit - Belle van Rosmalen

Belle Van Rosmalen

Director, Medical Development

Eli Lilly

MASH Drug Development Summit - Cynthia Arbeeny

Cynthia Arbeeny

Chief Scientific Officer

Mitotherapeutix

MASH Drug Development Summit - Cynthia Lebeaupin

Cynthia Lebeaupin

Senior Scientist, Inflammation & Immunology R&D

Pfizer

Erik Tillman

Director, Translational Biology and Pharmacology

Akero Therapeutics

MASH Drug Development Summit - Girish Rao

Girish Rao

Executive Director, Clinical Design- Cardiometabolic Health, Clinical Design Delivery & Analytics

Eli Lilly

MASH Drug Development Summit - Hank Mansbach

Hank Mansbach

Chief Medical Officer

89 Bio

MASH Drug Development Summit - Jen-Chieh Chuang

Jen-Chieh Chuang

Director, Translational Biomarker Lead, Liver Diseases

Takeda Pharmaceuticals

MASH Drug Development Summit - Julio Gutierrez

Julio Gutierrez

Senior Medical Director

Altimmune

MASH Drug Development Summit - Kavita Juneja

Kavita Juneja

Vice President - Endocrinology & Metabolic Clinical Development

Corcept Therapeutics

MASH Drug Development Summit - Kevin Hart

Kevin Hart

Associate Director - Scientific Research Fellow

Pfizer

MASH Drug Development Summit - Kristin Fiorino

Kristin Fiorino

Medical Director

AstraZeneca

MASH Drug Development Summit - Marie O'Farrell

Marie O’Farrell

Senior Vice President - Research & Development

Sagimet Biosciences

MASH Drug Development Summit - Oliver Yoa-Pu Hu

Oliver Yoa-Pu Hu

Scientific Board Member

Sinew Pharma

MASH Drug Development Summit - Patrice Mimche

Patrice Mimche

Associate Professor

Indiana University

MASH Drug Development Summit - Rebecca Taub

Rebecca Taub

MD, Founder & Director

Madrigal

MASH Drug Development Summit - Remi Laberge

Remi Laberge

CTO

Arda Therapeutics

MASH Drug Development Summit - Saheli Chowdhury

Saheli Chowdhury

Postdoctoral Research Scientist

Columbia University

MASH Drug Development Summit - Sharon Jaycox

Sharon Jaycox

Director

Global Liver Institute

MASH Drug Development Summit - Stanley Watowich

Stan Watowich

Founder & Chief Executive Officer

Ridgeline Therapeutics

MASH Drug Development Summit - Wen-Wei Tsai

Wen-Wei Tsai

Senior Director - Translational Sciences

Sagimet Biosciences

MASH Drug Development Summit - Winston Dunn

Winston Dunn

Professor

University of Kansas Medical Center

MASH Drug Development Summit - Zoltan Derdak

Zoltan Derdak

Director - Medical

Takeda Pharmaceuticals